Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Inhibitor inhibits ZUP1. 1 / 1

| 1

➶

eidos

"The residual activity observed in lysates treated with 50 muM PR-619 is an indication of incomplete inhibition of DUB activity by the inhibitor , suggesting that higher concentrations of the inhibitor would be needed to further decrease the level of DUB activity until a complete inhibition be potentially reached ."

32831622

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...